![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Celadon Pharmaceuticals Plc | LSE:CEL | London | Ordinary Share | GB00BDQYGP38 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.50 | 2.52% | 61.00 | 57.00 | 65.00 | 61.00 | 59.50 | 59.50 | 12,246 | 14:00:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investment Advice | 149k | -7.14M | -0.1082 | -5.64 | 39.26M |
RNS Number:0551N Celsis International PLC 02 June 2005 2nd June 2005 Celsis International plc ("the Company") Holding in Company Celsis International Plc announces that it received notification on 1st June 2005 that, as at 31st May 2005, Fidelity International Limited had a notifiable interest in 3,372,640 ordinary shares in the Company, including the notifiable interest of Mr Edward C. Johnson 3d, a principal shareholder of Fidelity International Limited. The registered holders of the notifiable interest in the Company are detailed below: Registered Holder Holding % JP Morgan, Bournemouth 2,799,040 Bank Of New York Brussels 573,600 This represents approximately 3.00 percent of the issued share capital of the Company. END This information is provided by RNS The company news service from the London Stock Exchange END HOLUURARVARNRAR
1 Year Celadon Pharmaceuticals Chart |
1 Month Celadon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions